Hans van der Boom

1.4k total citations
23 papers, 1.2k citations indexed

About

Hans van der Boom is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Hans van der Boom has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cancer Research. Recurrent topics in Hans van der Boom's work include Cancer, Lipids, and Metabolism (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). Hans van der Boom is often cited by papers focused on Cancer, Lipids, and Metabolism (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). Hans van der Boom collaborates with scholars based in Netherlands, Japan and United States. Hans van der Boom's co-authors include Louis M. Havekes, Marten H. Hofker, Rune R. Frants, Arn M. J. M. van den Maagdenberg, Marion J. Gijbels, Bart J. van Vlijmen, Theo J.C. van Berkel, Miek C. Jong, Patrick C.N. Rensen and Harm HogenEsch and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Hans van der Boom

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans van der Boom Netherlands	17	598	444	310	235	201	23	1.2k
Vincenzo Pierotti United States	15	437 0.7×	729 1.6×	340 1.1×	234 1.0×	181 0.9×	15	1.4k
Vivian E.H. Dahlmans Netherlands	22	411 0.7×	843 1.9×	362 1.2×	337 1.4×	123 0.6×	34	1.7k
Illiana Meurs Netherlands	21	911 1.5×	601 1.4×	321 1.0×	172 0.7×	277 1.4×	31	1.6k
Chien-Ping Liang United States	13	437 0.7×	646 1.5×	247 0.8×	101 0.4×	289 1.4×	13	1.4k
Mounib Elchebly Canada	17	311 0.5×	643 1.4×	167 0.5×	82 0.3×	164 0.8×	24	1.2k
Esa Tahvanainen Finland	24	337 0.6×	465 1.0×	397 1.3×	258 1.1×	95 0.5×	36	1.5k
Zhi‐Ming Ding United States	19	433 0.7×	700 1.6×	703 2.3×	478 2.0×	335 1.7×	47	1.9k
Marie Sanson United States	11	428 0.7×	630 1.4×	245 0.8×	163 0.7×	693 3.4×	12	1.7k
Mary Beth DeYoung United States	17	390 0.7×	659 1.5×	638 2.1×	81 0.3×	91 0.5×	23	1.4k
Pili Zhang United States	18	626 1.0×	637 1.4×	362 1.2×	75 0.3×	185 0.9×	22	1.5k

Countries citing papers authored by Hans van der Boom

Since Specialization

Citations

This map shows the geographic impact of Hans van der Boom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans van der Boom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans van der Boom more than expected).

Fields of papers citing papers by Hans van der Boom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans van der Boom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans van der Boom. The network helps show where Hans van der Boom may publish in the future.

Co-authorship network of co-authors of Hans van der Boom

This figure shows the co-authorship network connecting the top 25 collaborators of Hans van der Boom. A scholar is included among the top collaborators of Hans van der Boom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans van der Boom. Hans van der Boom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Delsing, Dianne J., Sabine M. Post, Martine Groenendijk, et al.. (2004). Rosuvastatin Reduces Plasma Lipids by Inhibiting VLDL Production and Enhancing Hepatobiliary Lipid Excretion in ApoE*3-Leiden Mice. Journal of Cardiovascular Pharmacology. 45(1). 53–60. 17 indexed citations

Mulder, Monique, Paula J. Jansen, Ben Janssen, et al.. (2004). Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiology of Disease. 16(1). 212–219. 79 indexed citations

Teusink, Bas, Arjen R. Mensenkamp, Hans van der Boom, et al.. (2001). Stimulation of the in Vivo Production of Very Low Density Lipoproteins by Apolipoprotein E Is Independent of the Presence of the Low Density Lipoprotein Receptor. Journal of Biological Chemistry. 276(44). 40693–40697. 18 indexed citations

Pijl, Hanno, Paul H. E. Meijer, J.A.E. Langius, et al.. (2001). Food Choice in Hyperthyroidism: Potential Influence of the Autonomic Nervous System and Brain Serotonin Precursor Availability. The Journal of Clinical Endocrinology & Metabolism. 86(12). 5848–5853. 45 indexed citations

Jong, Miek C., Patrick C.N. Rensen, Vivian E.H. Dahlmans, et al.. (2001). Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. Journal of Lipid Research. 42(10). 1578–1585. 124 indexed citations

Havekes, L.M., Hans van der Boom, J.J. Emeis, & P. Hans. (2000). New HMG-CoA reductase inhibitor ZD4522 lowers plasma lipids and VLDL production in APOE*3Leiden transgenic mice. Atherosclerosis. 151(1). 172–172. 4 indexed citations

Rensen, Patrick C.N., Miek C. Jong, Hans van der Boom, et al.. (2000). Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo. Journal of Biological Chemistry. 275(12). 8564–8571. 66 indexed citations

Delsing, Dianne J., J. Wouter Jukema, Hans van der Boom, et al.. (2000). Effects of amlodipine and atorvastatin on the development of atherosclerosis in ApoE*3-Leiden transgenic mice. Atherosclerosis. 151(1). 218–218. 1 indexed citations

Dijk, Ko Willems van, Bart J.M. van Vlijmen, Menno P.J. de Winther, et al.. (1999). Hyperlipidemia of ApoE2(Arg ₁₅₈ -Cys) and ApoE3-Leiden Transgenic Mice Is Modulated Predominantly by LDL Receptor Expression. Arteriosclerosis Thrombosis and Vascular Biology. 19(12). 2945–2951. 10 indexed citations

10.

Dijk, Ko Willems van, Bart J.M. van Vlijmen, André van der Zee, et al.. (1998). Reversal of Hypercholesterolemia in Apolipoprotein E2 and Apolipoprotein E3-Leiden Transgenic Mice by Adenovirus-Mediated Gene Transfer of the VLDL Receptor. Arteriosclerosis Thrombosis and Vascular Biology. 18(1). 7–12. 21 indexed citations

11.

Vlijmen, Bart J. van, M.J.T.M. Mol, Hans van der Boom, et al.. (1996). Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.. Journal of Clinical Investigation. 97(5). 1184–1192. 76 indexed citations

12.

Vlijmen, Bart J.M. van, Ko Willems van Dijk, Patrick J. van Gorp, et al.. (1996). In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice. Journal of Biological Chemistry. 271(48). 30595–30602. 45 indexed citations

13.

Boom, Hans van der, et al.. (1996). Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochemical Journal. 314(2). 563–568. 53 indexed citations

14.

Ree, Janine H. van, Marten H. Hofker, Walther J. A. A. van den Broek, et al.. (1995). Increased response to cholesterol feeding in apolipoprotein C1-deficient mice. Biochemical Journal. 305(3). 905–911. 39 indexed citations

15.

Mulder, Monique, Hans van der Boom, Peter de Knijff, et al.. (1994). Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins. Atherosclerosis. 108(2). 183–192. 15 indexed citations

16.

Vlijmen, Bart J. van, Arn M. J. M. van den Maagdenberg, Marion J. Gijbels, et al.. (1994). Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.. Journal of Clinical Investigation. 93(4). 1403–1410. 214 indexed citations

17.

Maagdenberg, Arn M. J. M. van den, Marten H. Hofker, Paul Krimpenfort, et al.. (1993). Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. Journal of Biological Chemistry. 268(14). 10540–10545. 192 indexed citations

18.

Lombardi, Pietro, et al.. (1993). Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment.. Journal of Biological Chemistry. 268(35). 26113–26119. 28 indexed citations

19.

Boom, Hans van der, Donald Schouten, Paul Roholl, et al.. (1991). Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver. Hepatology. 14(1). 79–90. 23 indexed citations

20.

Horbach, G. Jean, et al.. (1988). Molecular aspects of age-related changes in albumin synthesis in female WAG/Rij rats. Life Sciences. 43(21). 1707–1714. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact